Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 52520 | 107.06 |
09:34 ET | 9683 | 107.005 |
09:36 ET | 9676 | 107.35 |
09:38 ET | 21195 | 106.95 |
09:39 ET | 20930 | 106.76 |
09:41 ET | 5468 | 106.525 |
09:43 ET | 26813 | 106.015 |
09:45 ET | 30553 | 105.16 |
09:48 ET | 42939 | 105.54 |
09:50 ET | 11978 | 105.4448 |
09:52 ET | 33313 | 105.03 |
09:54 ET | 13921 | 105.06 |
09:56 ET | 27350 | 105.165 |
09:57 ET | 17988 | 105.105 |
09:59 ET | 15176 | 105.075 |
10:01 ET | 17541 | 104.5424 |
10:03 ET | 25429 | 104.75 |
10:06 ET | 29328 | 104.7 |
10:08 ET | 24142 | 105.35 |
10:10 ET | 12298 | 104.89 |
10:12 ET | 6530 | 105.0399 |
10:14 ET | 11371 | 104.88 |
10:15 ET | 5872 | 104.465 |
10:17 ET | 12065 | 104.69 |
10:19 ET | 14095 | 104.71 |
10:21 ET | 3313 | 104.7875 |
10:24 ET | 9879 | 105.25 |
10:26 ET | 5898 | 105.17 |
10:28 ET | 4748 | 105.33 |
10:30 ET | 5846 | 105.5 |
10:32 ET | 9675 | 105.65 |
10:33 ET | 5776 | 105.205 |
10:35 ET | 3796 | 105.135 |
10:37 ET | 7200 | 105.03 |
10:39 ET | 6756 | 105.0397 |
10:42 ET | 5860 | 104.88 |
10:44 ET | 7012 | 104.83 |
10:46 ET | 5974 | 104.6 |
10:48 ET | 2431 | 104.63 |
10:50 ET | 22034 | 103.88 |
10:51 ET | 8520 | 104.19 |
10:53 ET | 4965 | 104.025 |
10:55 ET | 6909 | 103.78 |
10:57 ET | 9447 | 103.73 |
11:00 ET | 6323 | 103.5492 |
11:02 ET | 2400 | 103.91 |
11:04 ET | 10474 | 103.84 |
11:06 ET | 16138 | 104.15 |
11:08 ET | 14146 | 104.415 |
11:09 ET | 53308 | 104.91 |
11:11 ET | 55157 | 104.7 |
11:13 ET | 11958 | 104.6201 |
11:15 ET | 13497 | 104.3365 |
11:18 ET | 3254 | 104.2524 |
11:20 ET | 6383 | 104 |
11:22 ET | 5168 | 104.21 |
11:24 ET | 7344 | 104.47 |
11:26 ET | 6410 | 104.1 |
11:27 ET | 6594 | 104.235 |
11:29 ET | 4594 | 104.31 |
11:31 ET | 5012 | 104.405 |
11:33 ET | 6040 | 104.14 |
11:36 ET | 1884 | 104.2 |
11:38 ET | 6015 | 104.145 |
11:40 ET | 1995 | 104.21 |
11:42 ET | 5135 | 104.3399 |
11:44 ET | 3034 | 104.37 |
11:45 ET | 11247 | 104.365 |
11:47 ET | 5135 | 104.385 |
11:49 ET | 3895 | 104.34 |
11:51 ET | 6280 | 104.71 |
11:54 ET | 8443 | 104.8138 |
11:56 ET | 4089 | 104.43 |
11:58 ET | 4474 | 104.47 |
12:00 ET | 2820 | 104.64 |
12:02 ET | 2140 | 104.68 |
12:03 ET | 2930 | 104.8047 |
12:05 ET | 1396 | 104.85 |
12:07 ET | 2654 | 104.76 |
12:09 ET | 1000 | 104.695 |
12:12 ET | 3421 | 104.82 |
12:14 ET | 9588 | 104.9312 |
12:16 ET | 3448 | 104.8701 |
12:18 ET | 3722 | 104.99 |
12:20 ET | 3802 | 104.935 |
12:21 ET | 6700 | 105.04 |
12:23 ET | 2415 | 104.955 |
12:25 ET | 6558 | 104.88 |
12:27 ET | 6188 | 104.695 |
12:30 ET | 9303 | 104.91 |
12:32 ET | 11794 | 104.7025 |
12:34 ET | 1379 | 104.79 |
12:36 ET | 1902 | 104.7953 |
12:38 ET | 7876 | 104.91 |
12:39 ET | 992 | 104.88 |
12:41 ET | 4128 | 105.17 |
12:43 ET | 2610 | 105.2927 |
12:45 ET | 3882 | 105.1001 |
12:48 ET | 4197 | 105.29 |
12:50 ET | 1000 | 105.25 |
12:52 ET | 1546 | 105.27 |
12:54 ET | 1100 | 105.28 |
12:56 ET | 1887 | 105.44 |
12:57 ET | 6963 | 105.1201 |
12:59 ET | 2440 | 104.88 |
01:01 ET | 1318 | 104.97 |
01:03 ET | 3076 | 105.085 |
01:06 ET | 2378 | 105.11 |
01:08 ET | 6700 | 105.17 |
01:10 ET | 16180 | 105.19 |
01:12 ET | 1696 | 105.015 |
01:14 ET | 805 | 104.95 |
01:15 ET | 451 | 104.945 |
01:17 ET | 1000 | 104.85 |
01:19 ET | 3061 | 104.84 |
01:21 ET | 100 | 104.915 |
01:24 ET | 1922 | 104.785 |
01:26 ET | 2100 | 104.79 |
01:28 ET | 2354 | 104.875 |
01:30 ET | 14108 | 104.8508 |
01:32 ET | 1533 | 104.97 |
01:33 ET | 2748 | 105.08 |
01:35 ET | 3359 | 105.12 |
01:37 ET | 2354 | 104.985 |
01:39 ET | 3473 | 105.23 |
01:42 ET | 3429 | 105.49 |
01:44 ET | 4243 | 105.56 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 41.7B | -8.5x | --- |
ICON PLC | 25.5B | 40.6x | +4.68% |
Biogen Inc | 29.4B | 25.3x | -18.14% |
Biontech SE | 20.9B | 21.2x | --- |
Grifols SA | 5.5B | 65.9x | --- |
Charles River Laboratories International Inc | 12.3B | 24.7x | +15.57% |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $41.7B |
---|---|
Revenue (TTM) | $6.8B |
Shares Outstanding | 382.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.57 |
EPS | $-12.39 |
Book Value | $36.27 |
P/E Ratio | -8.5x |
Price/Sales (TTM) | 6.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -61.90% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.